UNSPSC 51162708: Domiodol

This classification denotes a mucolytic agent with the molecular formula C5H9IO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) C1PXF8V06N, chemically known as 1,3-dioxolane-4-methanol, 2-(iodomethyl)-, (e,z)- but more generally known as domiodol, which bears US NIH Compound Identifier 43814. European Medicines Agency schedules Domiodol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06355MIG. The term DOMIODOL is an International Non-Proprietary Name.

UNSPSC 51162708 Domiodol, a Commodity code, encompasses pharmaceutical products state and local governments procure for healthcare delivery within correctional facilities, public health programs, and emergency response initiatives. The Washington State Department of Corrections and Seminole County, Florida represent the kinds of issuing bodies active under this code — correctional systems and county health departments sourcing parenteral nutrition solutions, intravenous products, naloxone, and drug deactivation systems to serve incarcerated populations and community health needs. Scope spans preparation and delivery of specialized pharmaceutical products including total parenteral nutrition (TPN) and peripheral parenteral nutrition (PPN) solutions, controlled substances for medical care, and opioid-reversal and drug-management equipment, with strict delivery timelines and evidence of clinical capability required from vendors.

Washington state and Florida show recent activity under the code. The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, due October 7, 2026, soliciting parenteral products, services, and equipment for eight correctional facilities across West, Central, and East regions, with an anticipated contract term from November 26, 2026 through June 30, 2030 and DOC planning to award up to three contractors per region; the solicitation emphasizes set-asides and aspirational goals for small businesses (25%), minority-owned businesses (10%), women-owned businesses (6%), and veteran-owned businesses (5%) per Washington state law. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, due July 26, 2023, for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford; the contract was offered as a two-year initial term with one-year renewal option.